Skip to main content Accessibility help
×
Home

Emergence of Carbapenem Resistance in Acinetobacter baumannii Recovered From Blood Cultures in Australia

  • Anton Y. Peleg (a1) (a2), Clare Franklin (a1), Jan M. Bell (a3) and Denis W. Spelman (a1)

Abstract

We describe the first emergence of carbapenem-resistant Acinetobacter baumannii in Australia. Ninety A. baumannii isolates recovered from cultures of blood specimens from 69 patients were analyzed. Overall, 58 isolates (64%) were resistant to meropenem. The χ2 test for linear trend revealed that emergence of carbapenem resistance was statistically significant during the 32-month study period. Selected isolates were of the same clonal type, and no genes encoding carbapenemases were identified.

Copyright

Corresponding author

Infectious Diseases Unit, Alfred Hospital, Commercial Road, Prahran, 3181, Melbourne, Victoria, Australia (antonpeleg@iprimus.com.au)

References

Hide All
1.Villegas, MV, Hartstein, AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24:284295.
2.Bergogne-Berezin, E, Towner, KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996;9:148165.
3.Nordmann, P, Poirel, L. Emerging carbapenemases in gram-negative aerobes. Clin Microbiol Infect 2002; 8:321331.
4.Quale, J, Bratu, S, Landman, D, Heddurshetti, R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City. Clin Infect Dis 2003; 37:214220.
5.Dalla-Costa, LM, Coelho, JM, Souza, HA, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003; 41:34033406.
6.Corbella, X, Montero, A, Pujol, M, et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38:40864095.
7.Jeon, BC, Jeong, SH, Bae, IK, et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in Korea. J Clin Microbiol 2005; 43:22412245.
8.Tenover, FC, Arbeit, RD, Goering, RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33:22332239.
9.Yan, JJ, Hsueh, PR, Ko, WC, et al. Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother 2001; 45:22242228.
10.Senda, K, Arakawa, Y, Ichiyama, S, et al. PCR detection of metallo-beta-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum beta-lactams. J Clin Microbiol 1996; 34:29092913.
11.Afzal-shah, M, Woodford, N, Livermore, DM. Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother 2001; 45:583588.
12.Poirel, L, Marque, S, Heritier, C, Segonds, C, Chabanon, G, Nordmann, P. OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49:202208.
13.Hughes, VM, Datta, N. Conjugative plasmids in bacteria of the ‘pre-antibiotic’ era. Nature 1983; 302:725726.
14.Ferreira, AC, Gobara, S, Costa, SE, et al. Emergence of resistance in Pseudomonas aeruginosa and Acinetobacter species after the use of antimicrobials for burned patients. Infect Control Hosp Epidemiol 2004; 25:868872.
15.Ibrahim, EH, Sherman, G, Ward, S, Fraser, VJ, Kollef, MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000; 118:146155.

Emergence of Carbapenem Resistance in Acinetobacter baumannii Recovered From Blood Cultures in Australia

  • Anton Y. Peleg (a1) (a2), Clare Franklin (a1), Jan M. Bell (a3) and Denis W. Spelman (a1)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed